Hear from an expert about self-collection in a healthcare setting

Be at the forefront of cervical cancer screening with BD Onclarity™ HVP Assay, the first and only FDA-approved HPV assay offering both extended genotyping and self-collection in a healthcare setting.

Latest resources

Discover our latest articles, webinars, press releases and updates in women's health.

Modern Healthcare: How is extended genotyping shaping the future of cervical cancer screening?
Cervical Cancer | News & Updates
Modern Healthcare: How is extended genotyping shaping the future of cervical cancer screening?
BD Onclarity™ HPV Assay with extended genotyping
Cervical Cancer | Brochures
BD Onclarity™ HPV Assay with extended genotyping
Press release: New study finds up to one-third of women receive clinical misdiagnosis of vaginitis
Vaginitis | News & Updates
Press release: New study finds up to one-third of women receive clinical misdiagnosis of vaginitis